Form 4: Outset Medical Director Kevin O'Boyle Granted 8,983 Restricted Stock Units

Outset Medical, Inc. Director Kevin C. O'Boyle has been granted 8,983 shares of common stock in the form of Restricted Stock Units (RSUs), increasing his direct beneficial ownership to 24,118 shares.

Summary

• Kevin C. O'Boyle, a Director of Outset Medical, Inc. (OM), acquired 8,983 shares of common stock on June 2, 2025.
• The acquisition was a grant of Restricted Stock Units (RSUs) at a price of $0.0 per share.
• Following this transaction, Mr. O'Boyle's direct beneficial ownership in Outset Medical, Inc. stands at 24,118 shares.
• The 8,983 RSUs are subject to a vesting schedule where 100% will vest upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's next Annual Meeting of Stockholders.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects standard director compensation and aligns insider interests with company performance, without indicating any negative operational or financial news.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a standard form of non-cash compensation for directors, indicating ongoing commitment and incentivization.

Future Outlook

The granted Restricted Stock Units (RSUs) are scheduled to vest upon the earlier of the one-year anniversary of the grant date (June 2, 2026) or the date of the Issuer's next Annual Meeting of Stockholders, indicating future share ownership for the director.

Industry Context

Form 4 filings are routine disclosures in the U.S. public markets, detailing changes in beneficial ownership by company insiders. RSU grants are a common component of executive and director compensation packages across various industries, including medical technology, to align interests with long-term company performance.

Corporate Governance

Related Party Transactions

• The grant of 8,983 Restricted Stock Units (RSUs) to Kevin C. O'Boyle, a director of Outset Medical, Inc., constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• Shareholders: The RSU grant represents a form of equity compensation that can lead to minor dilution upon vesting but is intended to align the director's interests with shareholder value creation.
• Director (Kevin C. O'Boyle): Receives equity compensation, incentivizing long-term commitment and performance tied to the company's stock price.

Next Steps

• The 8,983 Restricted Stock Units (RSUs) will vest upon the earlier of the one-year anniversary of the grant date (June 2, 2026) or the date of Outset Medical's next Annual Meeting of Stockholders.

Key Dates

Keywords

Outset Medical, OM, Form 4, Restricted Stock Units, RSU, Insider Transaction, Beneficial Ownership, Director Compensation, Equity Grant